Population Health Data: Strengthening Decisions for Life Sciences SMEs, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how life sciences SMEs can use population-scale health data to support research and development decisions. The featured speakers will discuss how linked genetic, biological and longitudinal data can inform biomarker research, patient stratification, risk prediction and real-world outcomes. Attendees will also explore how to evaluate whether a population research resource is well suited to a specific R&D question.

TORONTO, Nov. 5, 2026 /PRNewswire/ -- Life sciences small and medium-sized enterprises (SMEs) need to make high-stakes R&D decisions quickly, from understanding disease biology and validating biomarkers to identifying meaningful patient populations and generating evidence to support product development. Population-scale health data is creating new opportunities to answer these questions, without requiring SMEs to build equivalent research resources themselves. This webinar explores how SMEs can use population-scale health data to support evidence-driven decisions across the drug development lifecycle.

While population-scale health data offers significant potential, scale alone is not enough. The value of a population resource depends on whether it brings together the right populations, biological information, longitudinal health data and research capabilities to answer the evidence question at hand. Increasingly, the opportunity lies in connecting information across people, genetics, biology and time.

The featured panelists will explore how population-scale health data can be applied across the R&D lifecycle, from understanding disease and validating biomarkers to predicting risk, identifying meaningful subgroups and understanding outcomes over time. The session will also examine the questions SMEs should consider when evaluating a population research resource, helping teams begin with the evidence they need rather than simply the data available.

Register for this webinar to learn how SMEs can use population-scale health data to generate stronger evidence and inform research decisions.

Join Dr. Jared G. Maina, Research Associate, UK Dementia Research Institute, Imperial College London; Kamil Lipinski, Director of Science and Molecular Epidemiology, Our Future Health; and Helena Golaszewska, MPhil, BSc, Lead Computational Biologist, OutSee, for the live webinar on Monday, November 23, 2026, at 9:30am EST (3:30pm CET / EU-Central).

For more information, or to register for this event, visit Population Health Data: Strengthening Decisions for Life Sciences SMEs.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: skumar@xtalks.com

SOURCE Xtalks